Quantum Cyber N.V. (QUCY) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $286.06K; Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD $141.02M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m).
- 2026-03-31: Common Stock, Value, IssuedUSD $140.00K; Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD $115.05M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-652.75K.
- 2025-12-31: Common Stock, Value, IssuedUSD $107.82K; Additional Paid in Capital, Common StockUSD $106.05M; Additional Paid in CapitalUSD $106.05M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-617.65K.
- 2025-10-03: Common Stock, Value, IssuedUSD (m); Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m).
Quantum Cyber N.V. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Common Stock, Value, Outstanding USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Accumulated Other Comprehensive Income USD | Retained Earnings USD |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $286.06K | (m) | $141.02M | (m) | $-121.00M | $20.36M | (m) | 3 month · $-528.92K | (m) | (m) |
| 2026-03-31 | $140.00K | (m) | $115.05M | $-652.75K | $-109.98M | $4.59M | (m) | 3 month · $176.53K | (m) | (m) |
| 2025-12-31 | $107.82K | $106.05M | $106.05M | $-617.65K | $-104.90M | $641.60K | (m) | 12 month · $1.47M | (m) | (m) |
| 2025-10-03 | (m) | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) | (m) | $2.61M | (m) | 3 month · $160.19K | $-615.73K | $-99.32M |
| 2025-03-31 | (m) | (m) | (m) | (m) | (m) | $2.38M | (m) | 3 month · $856.29K | (m) | (m) |
| 2024-12-31 | $23.05K | $95.22M | (m) | $-548.63K | $-88.69M | $6.00M | (m) | (m) | $-556.87K | $-90.98M |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-514.68K | $-80.35M |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | $3.35M | (m) | (m) | $-452.31K | $-69.33M |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $383.05K | $-64.14M |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-98.41K | $-57.84M |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-8.39K | $-49.59M |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $52.18K | $-43.03M |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $85.12K | $-29.25M |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.48K | $-16.64M |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $-202.49K | $-4.95M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |